May 19, 2021 / 12:00PM GMT
Presentation
May 19, 2021 / 12:00PM GMT
=====================
Corporate Participants
=====================
* Daniel Schneider
Photocure ASA - President & CEO
* Erik Dahl
Photocure ASA - CFO
=====================
Daniel Schneider - Photocure ASA - President & CEO
All right. Well, good afternoon, everyone. Good morning to those who may be calling in from the U.S. My name is Dan Schneider. I'm President and CEO of Photocure. With me today is Erik Dahl, CFO. We're here to present Photocure's results for the first quarter of 2021.
Next slide. Just a reminder, typical disclaimers are in place for today's presentation. Next slide. What a fantastic quarter. 2021 highlights, we had 50% revenue growth on Hexvix and Cysview. Of course, some of this is due to the acquisition of European rights, but also some growth underlying growth.
EBITDA of positive NOK 18 million, so another quarter of positive EBITDA. We had 2 publications in the fourth -- in the first quarter. We had the World Journal of Urology and the British
Q1 2021 Photocure ASA Earnings Presentation Transcript
May 19, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers